Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 17Lung Neoplasms 6Head and Neck Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Ovarian Neoplasms 4Kidney Neoplasms 4Waldenstrom Macroglobulinemia 3Stomach Neoplasms 3Skin Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Liver Neoplasms 3Glioblastoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Uterine Cervical Neoplasms 2Sezary Syndrome 2Sarcoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Metastasectomy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Abdominal Neoplasms × Drug Therapy × Dermatologic × Clear all
NCT03966456 2019-05-29

Real World Study of Four PD-1 Agents in China

The Affiliated Hospital of Qingdao University

Unknown
500 enrolled
Dermatologic

Abdominal Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡